Effect of repeated nicotine exposure on high-affinity nicotinic acetylcholine receptor density in spontaneously hypertensive rats

Neuroscience Letters

Volumn 382, Issue 1-2, 2005, Pages 158-163

  Hohnadel, Elizabeth J ^a   Hernandez, Caterina M ^a   Gearhart, Debra A ^a   Terry Jr , Alvin V ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Acetylcholine; Attention; Autoradiography; Cholinergic; Cognition; Dementia

Indexed keywords

2 (2 IODO 5 PYRIDYL) 7 AZABICYCLO[2.2.1]HEPTANE; ALKALOID; EPIBATIDINE; IODINE 125; NICOTINE; NICOTINIC RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; ESSENTIAL HYPERTENSION; HYPOTHESIS; LONG TERM EXPOSURE; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEFICIENCY; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; SPONTANEOUSLY HYPERTENSIVE RAT; THALAMUS ANTERIOR NUCLEUS; THALAMUS DORSOMEDIAL NUCLEUS;

ANIMALS; AUTORADIOGRAPHY; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN CHEMISTRY; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, NICOTINIC; THALAMIC NUCLEI; UP-REGULATION;

EID: 19444374184     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.03.011     Document Type: Article

References (56)

1. F. Amenta, M.A. Di Tullio, and D. Tomassoni Arterial hypertension and brain damage - evidence from animal models (review) Clin. Exp. Hypertens. 25 2003 359 380
2. A. Blondel, D.J. Sanger, and P.C. Moser Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies Psychopharmacology (Berl.) 149 2000 293 305
3. C.R. Breese, M.J. Lee, C.E. Adams, B. Sullivan, J. Logel, K.M. Gillen, M.J. Marks, A.C. Collins, and S. Leonard Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia Neuropsychopharmacology 23 2000 351 364
4. I. Casserly, and E. Topol Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins Lancet 363 2004 1139 1146
5. C.K. Conners, E.D. Levin, E. Sparrow, S.C. Hinton, D. Erhardt, W.H. Meck, J.E. Rose, and J. March Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD) Psychopharmacol. Bull. 32 1996 67 73
6. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors J. Pharmacol. Exp. Ther. 282 1997 445 451
7. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol. Psychiatry 38 1995 22 33
8. M. Gattu, J.R. Pauly, K.L. Boss, J.B. Summers, and J.J. Buccafusco Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I Brain Res. 771 1997 89 103
9. M. Gattu, A.V. Terry Jr., J.R. Pauly, and J.J. Buccafusco Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II Brain Res. 771 1997 104 114
10. J.M. Gorell, B.A. Rybicki, C.C. Johnson, E.L. Peterson, and Smoking Parkinson's disease: a dose-response relationship Neurology 52 1999 115 119
11. A.J. Grottick, and G.A. Higgins Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task Behav. Brain Res. 117 2000 197 208
12. K. Hecht, M. Poppei, T. Hecht, J.W. Postnow, V. Moritz, and R. Baumann Learning and memory processes during postnatal ontogenesis in rats with spontaneous hypertension Acta Biol. Med. Ger. 37 1978 1471 1478
13. C.M. Hernandez, H. Hoifodt, and A.V. Terry Jr. Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression J. Psychiatry Neurosci. 28 2003 197 209
14. C.M. Hernandez, and A.V. Terry Jr. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor Neuroscience 130 2005 997 1012
15. K. Kellar, and S. Wonnacott Nicotinic cholinergic receptors in Alzheimer's disease S. Wonnacott M. Russell I. Stolerman Nicotinic Psychopharmacology: Molecular, Cellular, and Behavioral Aspects 1990 Oxford University Press Oxford 341 373
16. K.J. Kellar, P.J. Whitehouse, A.M. Martino-Barrows, K. Marcus, and D.L. Price Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex Brain Res. 436 1987 62 68
17. E.J. Khantzian The self-medication hypothesis of substance use disorders: a reconsideration and recent applications Harv. Rev. Psychiatry 4 1997 231 244
18. S. Knardahl, and K. Karlsen Passive-avoidance behavior of spontaneously hypertensive rats Behav. Neural Biol. 42 1984 9 22
19. P.N. Lee, and Smoking Smoking and Alzheimer's disease: A review of the epidemiological evidence Neuroepidemiology 13 1994 131 144
20. E.D. Levin, C.K. Conners, D. Silva, W. Canu, and J. March Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder Exp. Clin. Psychopharmacol. 9 2001 83 90
21. E.D. Levin, and A.H. Rezvani Development of nicotinic drug therapy for cognitive disorders Eur. J. Pharmacol. 393 2000 141 146
22. E.D. Levin, A. Wilkerson, J.P. Jones, N.C. Christopher, and S.J. Briggs Prenatal nicotine effects on memory in rats: pharmacological and behavioral challenges Brain Res. Dev. Brain Res. 97 1996 207 215
23. E.I. Majeski, C.E. Widener, and J. Basile Hypertension and dementia: does blood pressure control favorably affect cognition Curr. Hypertens. Rep. 6 2004 357 362
24. M.J. Marks, K.W. Smith, and A.C. Collins Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain J. Pharmacol. Exp. Ther. 285 1998 377 386
25. C. Martin-Ruiz, J. Court, M. Lee, M. Piggott, M. Johnson, C. Ballard, R. Kalaria, R. Perry, and E. Perry Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types Acta Neurol. Scand. Suppl. 176 2000 34 41
26. J.P. McEvoy, and T.B. Allen The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome Curr. Drug Targets. CNS Neurol. Disord. 1 2002 433 442
27. S. Mori, M. Kato, and M. Fujishima Impaired maze learning and cerebral glucose utilization in aged hypertensive rats Hypertension 25 1995 545 553
28. E.M. Nakamura-Palacios, C.K. Caldas, A. Fiorini, K.D. Chagas, K.N. Chagas, and E.C. Vasquez Deficits of spatial learning and working memory in spontaneously hypertensive rats Behav. Brain Res. 74 1996 217 227
29. P.A. Newhouse, A. Potter, M. Kelton, and J. Corwin Nicotinic treatment of Alzheimer's disease Biol. Psychiatry 49 2001 268 278
30. H.N. Nguyen, B.A. Rasmussen, and D.C. Perry Binding functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment J. Neurochem. 90 2004 40 49
31. H.N. Nguyen, B.A. Rasmussen, and D.C. Perry Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography J. Pharmacol. Exp. Ther. 307 2003 1090 1097 Epub 2003 October 14
32. A. Nordberg The effect of cholinesterase inhibitors studied with brain imaging E. Giacobini Cholinesterases and Cholinesterase Inhibitors 2000 Martin Dunitz London 237 247
33. A. Nordberg Noninvasive exploration of nicotinic acetylcholine receptors in vivo F. Clementi D. Fornasari C. Gotti Handbook of Experimental Pharmacology vol. 144 2000 Springer Berlin 539 561
34. A. Nordberg, I. Alafuzoff, and B. Winblad Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia J. Neurosci. Res. 31 1992 103 111
35. A. Nordberg, O. Almkvist, K. Amberla, H. Basun, B. Corder, T. Ebendal, C.G. Gottfries, P. Hartvig, E. Hellström-Lindahl, V. Jelic, M. Jönhagen, L. Lannfelt, W. Lehman, B. Långström, H. Lundquist, L. Meurling, B. Meyerson, L. Olson, Å. Seiger, S. Valind, M. Viitanen, L.O. Wahlund, and B. Winblad Responders and non-responders to tacrine, ondansetron and NGF treatment in Alzheimer patients as evaluated by positron emission tomography and APOE genotype K. Iqbal B. Winblad T. Nishimura M. Takeda H.M. Wisniewski Alzheimer's Disease: Biology, Diagnosis and Therapeutics 1997 Wiley Chichester, UK 647 653
36. A. Nordberg, H. Lundqvist, P. Hartvig, J. Andersson, M. Johansson, E. Hellstrom-Lindahi, and B. Langstrom Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment Dement. Geriatr. Cogn. Disord. 8 1997 78 84
37. A. Nordberg, H. Lundqvist, P. Hartvig, A. Lilja, and B. Langstrom Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains - in vivo assessment using positron emission tomography Alzheimer Dis. Assoc. Disord. 9 1995 21 27
38. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains Neurosci. Lett. 72 1986 115 119
39. G. Paxinos, and C.a.W. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press
40. E.K. Perry, M.L. Lee, C.M. Martin-Ruiz, J.A. Court, S.G. Volsen, J. Merrit, E. Folly, P.E. Iversen, M.L. Bauman, R.H. Perry, and G.L. Wenk Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain Am. J. Psychiatry 158 2001 1058 1066
41. E.K. Perry, C.M. Morris, J.A. Court, A. Cheng, A.F. Fairbairn, I.G. McKeith, D. Irving, A. Brown, and R.H. Perry Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology Neuroscience 64 1995 385 395
42. E.K. Perry, R.H. Perry, C.J. Smith, D.J. Dick, J.M. Candy, J.A. Edwardson, A. Fairbairn, and G. Blessed Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases J. Neurol. Neurosurg. Psychiatry 50 1987 806 809
43. S.L. Pimlott, M. Piggott, J. Owens, E. Greally, J.A. Court, E. Jaros, R.H. Perry, E.K. Perry, and D. Wyper Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380 Neuropsychopharmacology 29 2004 108 116
44. S. Potvin, E. Stip, and J.Y. Roy Schizophrenia and addiction: an evaluation of the self-medication hypothesis Encephale 29 2003 193 203
45. M. Prince, M. Cullen, and A. Mann Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial Neurology 44 1994 97 104
46. T. Sagvolden Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD) Neurosci. Biobehav. Rev. 24 2000 31 39
47. T. Sagvolden, M.A. Metzger, H.K. Schiorbeck, A.L. Rugland, I. Spinnangr, and G. Sagvolden The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants Behav. Neural Biol. 58 1992 103 112
48. T. Sagvolden, M.B. Pettersen, and M.C. Larsen Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains Physiol. Behav. 54 1993 1047 1055
49. R.D. Schwartz, and K.J. Kellar Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo Science 220 1983 214 216
50. S.L. Shalat, B. Seltzer, C. Pidcock, and E.L. Baker Jr. Risk factors for Alzheimer's disease: a case-control study Neurology 37 1987 1630 1633
51. J.R. Sutterer, W.J. DeVito, and I. Rykaszewski Developmental aspects of 2-way shuttlebox avoidance in the spontaneously hypertensive and normotensive rat Dev. Psychobiol. 14 1981 405 414
52. J.R. Sutterer, J. Perry, and W. DeVito Two-way shuttle box and lever-press avoidance in the spontaneously hypertensive and normotensive rat J. Comp. Physiol. Psychol. 94 1980 155 163
53. A.V. Terry Jr., C.M. Hernandez, J.J. Buccafusco, and M. Gattu Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats Neuroscience 101 2000 357 368
54. K. Ueno, H. Togashi, M. Matsumoto, S. Ohashi, H. Saito, and M. Yoshioka Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder J. Pharmacol. Exp. Ther. 302 2002 95 100
55. P.N. Wang, S.J. Wang, C.J. Hong, T.T. Liu, J.L. Fuh, C.W. Chi, C.Y. Liu, and H.C. Liu Risk factors for Alzheimer's disease: a case-control study Neuroepidemiology 16 1997 234 240
56. J.M. Wyss, G. Fisk, and T. van Groen Impaired learning and memory in mature spontaneously hypertensive rats Brain Res. 592 1992 135 140